Delivery Order SPE2DB22D3004-SPE2DB25FPB71

Award Date 1/13/25
Potential Completion Date 1/14/25
Potential Value $3.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract worth $1,383.36 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. This contract is for the delivery of 4,563,172,594 units of the prescription medication Depakote DR 250 mg tablets. The contract has a completion date of December 26, 2023 and uses a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,214.29 firm fixed-price contract is for the delivery of Depakote DR 125 mg medication sprinkle capsules. It is an open competition contract, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, which serves...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, valued at $1,276.08. The contract is for the delivery of Depakote ER 250 mg tablets, a medication used to treat certain types of seizures and mental health conditions. The contract is a firm fixed-price, delivery order type with a period of performance ending on November 13, 2024. This award is not associated with a set-aside program....
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of Depakote DR 125 mg sprinkle capsules, a prescription medication, with a ceiling value of $7,451.43 and a performance period through April 16, 2024. Amerisourcebergen Drug Corp is a subsidiary of the Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies globally....
This is a federal contract award valued at $1,170.88 to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, for the delivery of divalproex delayed-release capsules. The contract is a delivery order, with a firm fixed price pricing type and an ultimate completion date of November 26, 2024. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,290.00 Firm Fixed Price delivery order provides for the supply of DIVALPROEX SOD ER 500 MG TAB 100S, a prescription medication. The contract has an ultimate completion date of September 13, 2022 and was awarded on September 12, 2022. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical for the procurement of pharmaceutical products, including a tablet medication. The contract has a ceiling value of $13,929.10 and a completion date of January 13, 2025. Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 through November 2026, which serves as...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $37,582.44 and an ultimate completion date of November 18, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation, for the provision of various pharmaceutical products and medical supplies to support military healthcare...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $10,636.00 and a completion date of January 31, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, for the provision of various pharmaceutical products and medical supplies to support military healthcare programs. AmerisourceBergen holds a larger...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $1,689.44 and a completion date of January 24, 2025. It is a firm fixed-price contract for the delivery of various pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials,...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPB71
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of DEPAKOTE DR 500 MG TABLET 100S. The contract has a ceiling value of $3,376.57 and a completion date of January 14, 2025. The contract is a firm-fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, covering similar medical products and prescription drugs.

Generated 5/21/25, 10:29 AM